Nanoviricides annual debt-to-assets ratio
2012
2013
2014
2015
2016
2022
Nanoviricides Debt-to-Assets Ratio Growth & History (NNVC)
Nanoviricides's debt-to-assets ratio was 0.00 for fiscal 2022.
View full Nanoviricides company overviewNanoviricides annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-06-30 | 0.00 | — | — |
| 2016 | 2016-06-30 | 0.15 | 0.15 | — |
| 2015 | 2015-06-30 | 0.00 | −0.11 | — |
| 2014 | 2014-06-30 | 0.11 | −0.10 | −46.07% |
| 2013 | 2013-06-30 | 0.21 | 0.21 | — |
| 2012 | 2012-06-30 | 0.00 | — | — |
Nanoviricides quarterly debt-to-assets ratio
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | 0.00 | 0.00 | — |
| Q2 2026 | 2025-12-31 | 0.00 | 0.00 | — |
| Q1 2026 | 2025-09-30 | 0.00 | 0.00 | — |
| Q4 2025 | 2025-06-30 | 0.00 | 0.00 | — |
| Q3 2025 | 2025-03-31 | 0.00 | 0.00 | — |
| Q2 2025 | 2024-12-31 | 0.00 | 0.00 | — |
| Q1 2025 | 2024-09-30 | 0.00 | 0.00 | — |
| Q4 2024 | 2024-06-30 | 0.00 | 0.00 | — |
| Q3 2024 | 2024-03-31 | 0.00 | 0.00 | — |
| Q2 2024 | 2023-12-31 | 0.00 | 0.00 | — |
| Q1 2024 | 2023-09-30 | 0.00 | 0.00 | — |
| Q4 2023 | 2023-06-30 | 0.00 | 0.00 | — |
| Q3 2023 | 2023-03-31 | 0.00 | 0.00 | — |
| Q2 2023 | 2022-12-31 | 0.00 | 0.00 | — |
| Q1 2023 | 2022-09-30 | 0.00 | 0.00 | — |
| Q4 2022 | 2022-06-30 | 0.00 | 0.00 | — |
| Q3 2022 | 2022-03-31 | 0.00 | 0.00 | — |
| Q2 2022 | 2021-12-31 | 0.00 | 0.00 | — |
| Q1 2022 | 2021-09-30 | 0.00 | 0.00 | — |
| Q4 2021 | 2021-06-30 | 0.00 | 0.00 | — |
| Q3 2021 | 2021-03-31 | 0.00 | 0.00 | — |
| Q2 2021 | 2020-12-31 | 0.00 | 0.00 | — |
| Q1 2021 | 2020-09-30 | 0.00 | 0.00 | — |
| Q4 2020 | 2020-06-30 | 0.00 | 0.00 | — |
| Q3 2020 | 2020-03-31 | 0.00 | 0.00 | — |
| Q2 2020 | 2019-12-31 | 0.00 | 0.00 | — |
| Q1 2020 | 2019-09-30 | 0.00 | 0.00 | — |
| Q4 2019 | 2019-06-30 | 0.00 | 0.00 | — |
| Q3 2019 | 2019-03-31 | 0.00 | 0.00 | — |
| Q2 2019 | 2018-12-31 | 0.00 | 0.00 | — |
| Q1 2019 | 2018-09-30 | 0.00 | 0.00 | — |
| Q4 2018 | 2018-06-30 | 0.00 | 0.00 | — |
| Q3 2018 | 2018-03-31 | 0.00 | 0.00 | — |
| Q2 2018 | 2017-12-31 | 0.00 | −0.19 | — |
| Q1 2018 | 2017-09-30 | 0.00 | −0.17 | — |
| Q4 2017 | 2017-06-30 | 0.00 | −0.15 | — |
| Q3 2017 | 2017-03-31 | 0.00 | −0.14 | — |
| Q2 2017 | 2016-12-31 | 0.19 | 0.19 | — |
| Q1 2017 | 2016-09-30 | 0.17 | 0.17 | — |
| Q4 2016 | 2016-06-30 | 0.15 | 0.15 | — |
| Q3 2016 | 2016-03-31 | 0.14 | 0.14 | — |
| Q2 2016 | 2015-12-31 | 0.00 | 0.00 | — |
| Q1 2016 | 2015-09-30 | 0.00 | 0.00 | — |
| Q4 2015 | 2015-06-30 | 0.00 | −0.11 | — |
| Q3 2015 | 2015-03-31 | 0.00 | −0.09 | — |
| Q2 2015 | 2014-12-31 | 0.00 | −0.16 | — |
| Q1 2015 | 2014-09-30 | 0.00 | −0.14 | — |
| Q4 2014 | 2014-06-30 | 0.11 | −0.10 | −46.07% |
| Q3 2014 | 2014-03-31 | 0.09 | −0.09 | −49.18% |
| Q2 2014 | 2013-12-31 | 0.16 | 0.16 | — |
| Q1 2014 | 2013-09-30 | 0.14 | 0.14 | — |
| Q4 2013 | 2013-06-30 | 0.21 | 0.21 | — |
| Q3 2013 | 2013-03-31 | 0.19 | — | — |
| Q2 2013 | 2012-12-31 | 0.00 | — | — |
| Q1 2013 | 2012-09-30 | 0.00 | — | — |
| Q4 2012 | 2012-06-30 | 0.00 | — | — |
Nanoviricides debt-to-assets ratio trends
Between the periods ended 2012-06-30 and 2022-06-30, Nanoviricides's debt-to-assets ratio increased from 0.00 to 0.00, a change of 0.00. The latest reported quarter, Q3 2026, shows 0.00.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanoviricides source filings ↗